Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites
- PMID: 6707913
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites
Abstract
The relative abilities of putative serotonin (5-HT) antagonists to block the quipazine discriminative cue were compared with their relative potencies to compete for the 5-HT1 and 5-HT2 binding sites in the brain. Male Sprague-Dawley rats were trained to discriminate 2.5 mg/kg of quipazine from saline. Once training was complete, antagonists were administered 90 min before a 5-min test with 1 mg/kg of quipazine, a dose which gave 75% responding on the quipazine lever. A dose-response curve was generated for each antagonist and an ID50 value (dose that inhibits responding to 50% on the quipazine lever) was determined by log-logit analysis. The binding of [3H]-5-HT to the 5-HT1 site and of [3H]spiperone to the 5-HT2 site was determined in crude membranes prepared from frontal cortex ( [3H]spiperone) or pons-medulla ( [3H]-5-HT) of naive rats. IC50 values for the antagonists were determined by log-logit analyses of competition binding curves. The ID50 values for the blockade of the quipazine discrimination by the 5-HT antagonists correlated significantly with their affinities for the 5-HT2 binding site (r = 0.87). In contrast, no correlation existed between effects on the behavioral measure and affinities for the 5-HT1 site (r = 0.15). These results suggest that the quipazine cue is mediated by an action at central 5-HT2 sites.
Similar articles
-
Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.J Pharmacol Exp Ther. 1991 Sep;258(3):999-1007. J Pharmacol Exp Ther. 1991. PMID: 1890629
-
Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.J Pharmacol Exp Ther. 1991 Nov;259(2):772-82. J Pharmacol Exp Ther. 1991. PMID: 1941625
-
Relationship between receptors mediating serotonin (5-HT) contractions in the canine basilar artery to 5-HT1, 5-HT2 and rat stomach fundus 5-HT receptors.J Pharmacol Exp Ther. 1986 Jun;237(3):713-8. J Pharmacol Exp Ther. 1986. PMID: 3712277
-
Multiple serotonin receptors and their physiological significance.Fed Proc. 1983 Feb;42(2):213-7. Fed Proc. 1983. PMID: 6337063 Review.
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
Cited by
-
Discriminative stimulus properties of the serotonin agonist MK 212.Psychopharmacology (Berl). 1986;90(2):193-7. doi: 10.1007/BF00181240. Psychopharmacology (Berl). 1986. PMID: 3097699
-
Abnormal development of monoaminergic neurons is implicated in mood fluctuations and bipolar disorder.Neuropsychopharmacology. 2015 Mar;40(4):839-48. doi: 10.1038/npp.2014.244. Epub 2014 Sep 22. Neuropsychopharmacology. 2015. PMID: 25241801 Free PMC article.
-
Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse.Psychopharmacology (Berl). 1985;86(1-2):223-7. doi: 10.1007/BF00431714. Psychopharmacology (Berl). 1985. PMID: 3927360
-
Evidence for 5-HT2 receptor mediation in quipazine anorexia.Psychopharmacology (Berl). 1990;100(1):115-8. doi: 10.1007/BF02245800. Psychopharmacology (Berl). 1990. PMID: 2296618
-
The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis.Psychopharmacology (Berl). 1995 Oct;121(3):347-56. doi: 10.1007/BF02246074. Psychopharmacology (Berl). 1995. PMID: 8584617